ABBVIE DRN (Brazil) Today

Equity ratings for ABBVIE DRN are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of April 2021 and ending today, the 25th of July 2021. Click here to learn more.
ABBVIE DRN cannot be verified against its exchange. It appears that ABBVIE DRN is not available for investing at the moment. Please verify the symbol is currently traded on Sao Paolo Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.

ABBVIE DRN Stock Profile

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. ABBVIE DRN operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 30000 people.. The public information regarding ABBVIE DRN's current market price is not available at this time.
ABBVIE DRN is not yet fully synchronised with the market data
ABBVIE DRN has some characteristics of a very speculative penny stock
Chairman of the Board, CEORichard Gonzalez  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of ABBVIE DRN's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
ABBVIE DRN (ABBV34) is traded on Sao Paolo Stock Exchange in Brazil and employs 30,000 people. The company currently falls under 'Mega-Cap' category with current market capitalization of 376.87 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ABBVIE DRN's market, we take the total number of its shares issued and multiply it by ABBVIE DRN's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. ABBVIE DRN operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 1.48 B outstanding shares. ABBVIE DRN has accumulated about 5.23 B in cash with 13.8 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.54.
Check ABBVIE DRN Probability Of Bankruptcy

ABBVIE Stock Against Markets

Picking the right benchmark for ABBVIE DRN stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ABBVIE DRN stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ABBVIE DRN is critical whether you are bullish or bearish towards ABBVIE DRN at a given time.
ABBVIE DRN cannot be verified against its exchange. It appears that ABBVIE DRN is not available for investing at the moment. Please verify the symbol is currently traded on Sao Paolo Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ABBVIE DRN stock to make a market-neutral strategy. Peer analysis of ABBVIE DRN could also be used in its relative valuation, which is a method of valuing ABBVIE DRN by comparing valuation metrics with similar companies.

ABBVIE DRN Corporate Directors

ABBVIE DRN corporate directors refer to members of an ABBVIE DRN board of directors. The board of directors generally takes responsibility for the ABBVIE DRN's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of ABBVIE DRN's board members must vote for the resolution. The ABBVIE DRN board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Frederick Waddell - Independent DirectorProfile
Robert Alpern - Independent DirectorProfile
Glenn Tilton - Lead Independent DirectorProfile
Rebecca Roberts - Independent DirectorProfile
Check out Trending Equities. Note that the ABBVIE DRN information on this page should be used as a complementary analysis to other ABBVIE DRN's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Tools for ABBVIE Stock

When running ABBVIE DRN price analysis, check to measure ABBVIE DRN's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABBVIE DRN is operating at the current time. Most of ABBVIE DRN's value examination focuses on studying past and present price action to predict the probability of ABBVIE DRN's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ABBVIE DRN's price. Additionally, you may evaluate how the addition of ABBVIE DRN to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
CEO Directory
Screen CEOs from public companies around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital